Abstract
Annexin A1 (ANXA1) is a 37 kDa protein capable of mimicking the anti-inflammatory action of glucocorticoids by inhibiting the synthesis of eicosanoids and phospholipase A2 (FLA2), affecting components of the inflammatory reaction and release of arachidonic acid. Studies have been revealed that the synthetic peptides of the N-terminal domain of ANXA1 mimic the pharmacological property of t…